A compounding pharmacy that prepares medications based on individual prescriptions. Subject to state board of pharmacy oversight.
"503A Pharmacy" is filed under Regulatory in the PeptideAtlas glossary, alongside 17 other terms in that group.
A compounding facility registered with the FDA that can produce compounded medications in larger quantities without individual prescriptions, subject to FDA inspection.
A medication prepared by a licensed compounding pharmacy to meet an individual patient's specific needs. Subject to different regulations than manufactured drugs.
A regulatory designation indicating a product is intended solely for laboratory research and is not approved for human consumption or therapeutic use.
More Regulatory terms: 503B Outsourcing Facility, Compounded Medication, Research Use Only (RUO), WADA (World Anti-Doping Agency), FDA Category 2, FDA Category 1, Class II Recall, Drug Shortage Declaration, PCAC (Pharmacy Compounding Advisory Committee), USP (United States Pharmacopeia), IND (Investigational New Drug), Bulk Drug Substance, Off-Label Use, Orphan Drug, EMA (European Medicines Agency), TGA (Therapeutic Goods Administration), MHRA (Medicines and Healthcare products Regulatory Agency).